drugset / Trial / NCT00065312
An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes
Treatment
Summary
The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | naveglitazar | Small molecule | — | — |